Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalFRA:O66 -5.84%8 3-Year ROIIC % is -18.92 as of Dec. 2025. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 113 Medical Distribution companies, 160 Health International ranks worse than 81.42% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
160 Health International's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -18.92%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for 160 Health International's 3-Year ROIIC % or its related term are showing as below:
FRA:O66's 3-Year ROIIC % is ranked worse than 81.42% of 113
companies
in the Medical Distribution industry
Industry Median: 2.39
vs FRA:O66: -18.92
160 Health International (FRA:O66) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
160 Health International 3-Year ROIIC % Related Terms
160 Health International 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:O66 vs MCK, COR, CAH: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, 160 Health International's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
160 Health International 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 160 Health International's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where 160 Health International's 3-Year ROIIC % falls into.
160 Health International 3-Year ROIIC % Calculation
160 Health International's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -7.401984 (Dec. 2025) - -10.594 (Dec. 2022) )
/
( 40.418 (Dec. 2025) - 57.426 (Dec. 2022) )
=
3.192016
/
-17.008
=
-18.77%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
160 Health International (FRA:O66) has a 3-Year ROIIC % of -18.92 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on 160 Health International and its competitors. According to the industry distribution chart, 160 Health International ranks #92 out of 113 companies in the Medical Distribution industry, placing it in the top 81.4%.
Is 160 Health International's 3-Year ROIIC % too high?
160 Health International's current 3-Year ROIIC % is -18.92. Based on the distribution chart, 160 Health International ranks #92 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's 3-Year ROIIC % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #92 out of 113 companies for 3-Year ROIIC %. This places 160 Health International in the lower half of its industry. The industry median 3-Year ROIIC % is 2.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.39, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current 3-Year ROIIC % is -18.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current 3-Year ROIIC % of -18.92. The current 3-Year ROIIC % is -18.92. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current 3-Year ROIIC % is -18.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for FRA:O66
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:O66 has been successfully added to your 
